Reintervention rate in glaucoma filtering surgery: A systematic review and meta-analysis.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 28 4 2022
medline: 13 8 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

Reintervention rate is an important factor impacting on patients, surgeons, and society. To date, only a few studies have focused on this topic. For this reason, a systematic review and meta-analysis was undertaken to assess the reintervention rate after glaucoma filtering surgery. Prospective studies reporting the reintervention rate after glaucoma filtering surgery and with at least 12 months of follow-up were systematically searched on PubMed, Medline and Embase databases. The primary outcome was the total reintervention rate following surgery. Secondary outcomes were: the rate of manipulation, in-clinic and in-operating room reintervention; the reintervention rate for intraocular pressure (IOP) control and for complications; demographic, clinical and surgical variables associated with reintervention rate. Ninety-three studies with a total of 8345 eyes were eligible. The total reintervention rate was 1.84 (95% CI 1.57-2.13), with a lower rate for Baerveldt (0.53, 95% CI 0.29-0.83) and Preserflo (0.60, 95% CI 0.15-1.29), and a higher rate for Xen (4.26, 95% CI 2.59-6.31). The manipulation rate was 0.99 (95% CI 0.77-1.23), the in-clinic reintervention rate was 0.08 (95% CI 0.05-0.12) and the in-operating room reintervention rate was 0.28 (95% CI 0.22-0.35). The reintervention rate for IOP control was 1.26 (95% CI 1.04-1.51) and the reintervention rate for complications was 0.27 (95% CI 0.21-0.35). All types of surgery presented a total reintervention rate similar to the overall findings, except studies on Baerveldt and Preserflo Microshunt, with a lower rate, and Xen, with a higher rate. None of the variables evaluated were found to be directly associated with the explored outcomes.

Identifiants

pubmed: 35473447
doi: 10.1177/11206721221093828
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2515-2531

Auteurs

Paola Marolo (P)

Department of Surgical Sciences, Eye Clinic Section, 60265University of Turin, Turin, Italy.

Michele Reibaldi (M)

Department of Surgical Sciences, Eye Clinic Section, 60265University of Turin, Turin, Italy.

Matteo Fallico (M)

Department of Ophthalmology, 9298University of Catania, Catania, Italy.

Andrea Maugeri (A)

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", 9298University of Catania, Catania, Italy.

Martina Barchitta (M)

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", 9298University of Catania, Catania, Italy.

Antonella Agodi (A)

Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", 9298University of Catania, Catania, Italy.

Guglielmo Parisi (G)

Department of Surgical Sciences, Eye Clinic Section, 60265University of Turin, Turin, Italy.

Paolo Caselgrandi (P)

Department of Surgical Sciences, Eye Clinic Section, 60265University of Turin, Turin, Italy.

Luca Ventre (L)

Department of Surgical Sciences, Eye Clinic Section, 60265University of Turin, Turin, Italy.

Iqbal Ike K Ahmed (IIK)

Department of Ophthalmology & Vision Sciences, 7938University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH